サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1075605

インスリンデリバリー装置の世界市場規模調査：タイプ別（ペン、ポンプ、ペンニードル、その他）、エンドユーザー別（患者/在宅医療、病院・診療所）、地域別予測（2022年～2028年）

Global Insulin Delivery Devices Market Size study, by Type (Pens, Pumps, Pen Needles Syringes, Other Devices), by End User( Patients/Homecare, Hospitals & Clinics) and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
インスリンデリバリー装置の世界市場規模調査：タイプ別（ペン、ポンプ、ペンニードル、その他）、エンドユーザー別（患者/在宅医療、病院・診療所）、地域別予測（2022年～2028年）
出版日: 2022年05月09日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のインスリンデリバリー装置市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のインスリンデリバリー装置市場の定義と範囲

第3章 世界のインスリンデリバリー装置市場力学

  • インスリンデリバリー装置市場の影響分析（2020年～2028年）

第4章 世界のインスリンデリバリー装置市場の業界分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ（2018年～2028年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 世界のインスリンデリバリー装置市場：タイプ別

  • 市場スナップショット
  • 世界のインスリンデリバリー装置市場実績：タイプ別－潜在分析
  • 世界のインスリンデリバリー装置市場の推定と予測（10億米ドル）（2018年～2028年）：タイプ別
  • インスリンデリバリー装置市場、サブセグメント分析
    • ペン
    • ポンプ
    • ペン針
    • 注射器
    • その他

第7章 世界のインスリンデリバリー装置市場：エンドユーザー別

  • 市場スナップショット
  • 世界のインスリンデリバリー装置市場実績：エンドユーザー別－潜在分析
  • 世界のインスリンデリバリー装置市場の推定と予測（10億米ドル）（2018年～2028年）：エンドユーザー別
  • インスリンデリバリー装置市場、サブセグメント分析
    • 患者/在宅医療
    • 病院とクリニック

第8章 世界のインスリンデリバリー装置市場、地域分析

  • 地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Becton, Dickinson and Company
    • Novo Nordisk A/S
    • Medtronic PLC
    • Sanofi
    • ELI Lilly and Company
    • Ypsomed Holding AG
    • Animas Corporation(Johnson and Johnson)
    • Tandem Diabetes Care, Inc.
    • Insulet Corporation
    • Biocon Limited

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Insulin Delivery Devices Market, report scope
  • TABLE 2. Global Insulin Delivery Devices Market estimates & forecasts by Region 2018-2028 (USDBillion)
  • TABLE 3. Global Insulin Delivery Devices Market estimates & forecasts byType2018-2028 (USDBillion)
  • TABLE 4. Global Insulin Delivery Devices Market estimates & forecasts byEnd-user 2018-2028 (USDBillion)
  • TABLE 5. Global Insulin Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 6. Global Insulin Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 7. Global Insulin Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 8. Global Insulin Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 9. Global Insulin Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 10. Global Insulin Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 11. Global Insulin Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 12. Global Insulin Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 13. Global Insulin Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 14. Global Insulin Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 15. U.S. Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 16. U.S. Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 17. U.S. Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 18. Canada Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 19. Canada Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 20. Canada Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 21. UK Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 22. UKInsulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 23. UKInsulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 24. Germany Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 25. Germany Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 26. Germany Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 27. RoEInsulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 28. RoEInsulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 29. RoEInsulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 30. China Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 31. China Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 32. China Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 33. India Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 34. India Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 35. India Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 36. Japan Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 37. Japan Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 38. Japan Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 39. RoAPAC Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 40. RoAPACInsulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 41. RoAPAC Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 42. Brazil Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 43. Brazil Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 44. Brazil Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 45. Mexico Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 46. Mexico Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 47. Mexico Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 48. RoLAInsulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 49. RoLAInsulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 50. RoLAInsulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 51. Row Insulin Delivery Devices Market estimates & forecasts, 2018-2028 (USDBillion)
  • TABLE 52. Row Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 53. Row Insulin Delivery Devices Market estimates & forecasts by segment 2018-2028 (USDBillion)
  • TABLE 54. List of secondary sources, used in the study of global Insulin Delivery Devices Market
  • TABLE 55. List of primary sources, used in the study of global Insulin Delivery Devices Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Insulin Delivery Devices Market, research methodology
  • FIG 2. Global Insulin Delivery Devices Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Insulin Delivery Devices Market, key trends 2021
  • FIG 5. Global Insulin Delivery Devices Market, growth prospects 2022-2028
  • FIG 6. Global Insulin Delivery Devices Market, porters 5 force model
  • FIG 7. Global Insulin Delivery Devices Market, pest analysis
  • FIG 8. Global Insulin Delivery Devices Market, value chain analysis
  • FIG 9. Global Insulin Delivery Devices Market by segment, 2018 & 2028 (USDBillion)
  • FIG 10. Global Insulin Delivery Devices Market by segment, 2018 & 2028 (USDBillion)
  • FIG 11. Global Insulin Delivery Devices Market by segment, 2018 & 2028 (USDBillion)
  • FIG 12. Global Insulin Delivery Devices Market by segment, 2018 & 2028 (USDBillion)
  • FIG 13. Global Insulin Delivery Devices Market by segment, 2018 & 2028 (USDBillion)
  • FIG 14. Global Insulin Delivery Devices Market, regional snapshot 2018 & 2028
  • FIG 15. North America Insulin Delivery Devices Market2018 & 2028 (USDBillion)
  • FIG 16. Europe Insulin Delivery Devices Market2018 & 2028 (USDBillion)
  • FIG 17. Asia pacific Insulin Delivery Devices Market2018 & 2028 (USDBillion)
  • FIG 18. Latin America Insulin Delivery Devices Market2018 & 2028 (USDBillion)
  • FIG 19. Global Insulin Delivery Devices Market, company Market share analysis (2021)
目次

Global Insulin Delivery Devices Market is valued approximately USD 12.5 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7x% over the forecast period 2022-2028.Insulin is an essential component of the treatment strategy for all patients with Type 1 diabetes, as well as many people with Type 2. Insulin aids in the transport of glucose from the bloodstream into muscle and fat cells for use as fuel. It cannot be taken as a tablet or a liquid because the digestive system would break it down before it reached the bloodstream, where insulin works. Insulin is therefore injected or infused into the fatty tissue beneath the skin.

The favourable reimbursement scenario and strong government backing in selected countries, technological improvements in insulin delivery devices, a growing diabetes population, and expanding knowledge of insulin delivery devices all contribute to the overall market's growth. According to the International Diabetes Federation (IDF) in the year 2021, Diabetes affects around 537 million persons aged 20 to 79. By 2030, the overall number of diabetics is expected to reach 643 million, and by 2045, it will reach 783 million.. Diabetes also caused 1.5 million fatalities worldwide in 2019. Aside from mortality, the illness causes blindness, amputations, kidney failure, stroke, and heart attacks, making it a devastating reality for millions of people worldwide. Insulin delivery systems continue to be critical to the health of millions of diabetics worldwide, and prospective applications of these with precise dosage delivery remain significant drivers of growth in the insulin delivery devices market. However, poor reimbursement structure in developing countries is expected to hamper the market growth.

The key regions considered for the global Insulin Delivery Devices Marketstudy includes Asia Pacific, North America, Europe, Latin America, and Rest of the World.The largest share of the global market was held by North America. This expansion can be attributed to rising diabetes prevalence, favourable reimbursement scenarios in the United States and Canada, increased venture capital investments and IPO issuance in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States. While Europe will continue to dominate the market, Asia will grow at the quickest rate during the projection period. The increasing population and growing geriatric and diabetic populations are responsible for the rise of the Asian market.

Major market player included in this report are:

Becton, Dickinson and Company

Novo Nordisk A/S

Medtronic PLC

Sanofi

ELI Lilly and Company

Ypsomed Holding AG

Animas Corporation (Johnson and Johnson)

Tandem Diabetes Care, Inc.

Insulet Corporation

Biocon Limited

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Pens

Pumps

Pen Needles

Syringes

Other Devices

By End user:

Patients/Homecare

Hospitals & Clinics

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Animal HealthMarket in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Insulin Delivery Devices Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Insulin Delivery Devices Market, by Type,2020-2028 (USD Billion)
    • 1.2.3. Insulin Delivery Devices Market, by End-user ,2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Insulin Delivery Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Insulin Delivery Devices Market Dynamics

  • 3.1. Insulin Delivery Devices Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing diabetic population
      • 3.1.1.2. Technological advancements in insulin delivery devices
    • 3.1.2. Market Challenges
      • 3.1.2.1. Issues Associated with the reuse of pen needles and infusion sets
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing Diabetes-related health expenditure in emerging economies

Chapter 4. Global Insulin Delivery Devices MarketIndustry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Insulin Delivery Devices Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Insulin Delivery Devices Market by Type, Performance - Potential Analysis
  • 6.3. Global Insulin Delivery Devices Market Estimates & Forecasts by Type2018-2028 (USD Billion)
  • 6.4. Insulin Delivery Devices Market, Sub Segment Analysis
    • 6.4.1. Pens
    • 6.4.2. Pumps
    • 6.4.3. Pen Needles
    • 6.4.4. Syringes
    • 6.4.5. Other Devices

Chapter 7. Global Insulin Delivery Devices Market, by End-user

  • 7.1. Market Snapshot
  • 7.2. Global Insulin Delivery Devices Market by End-user , Performance - Potential Analysis
  • 7.3. Global Insulin Delivery Devices Market Estimates & Forecasts by End-user 2018-2028 (USD Billion)
  • 7.4. Insulin Delivery Devices Market, Sub Segment Analysis
    • 7.4.1. Patients/Homecare
    • 7.4.2. Hospitals & Clinics

Chapter 8. Global Insulin Delivery Devices Market, Regional Analysis

  • 8.1. Insulin Delivery Devices Market, Regional Market Snapshot
  • 8.2. North America Insulin Delivery Devices Market
    • 8.2.1. U.S.Insulin Delivery Devices Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. End-user breakdown estimates & forecasts, 2018-2028
    • 8.2.2. CanadaInsulin Delivery Devices Market
  • 8.3. Europe Insulin Delivery Devices Market Snapshot
    • 8.3.1. U.K. Insulin Delivery Devices Market
    • 8.3.2. Germany Insulin Delivery Devices Market
    • 8.3.3. France Insulin Delivery Devices Market
    • 8.3.4. Spain Insulin Delivery Devices Market
    • 8.3.5. Italy Insulin Delivery Devices Market
    • 8.3.6. Rest of EuropeInsulin Delivery Devices Market
  • 8.4. Asia-PacificInsulin Delivery Devices Market Snapshot
    • 8.4.1. China Insulin Delivery Devices Market
    • 8.4.2. India Insulin Delivery Devices Market
    • 8.4.3. JapanInsulin Delivery Devices Market
    • 8.4.4. Australia Insulin Delivery Devices Market
    • 8.4.5. South Korea Insulin Delivery Devices Market
    • 8.4.6. Rest of Asia PacificInsulin Delivery Devices Market
  • 8.5. Latin America Insulin Delivery Devices Market Snapshot
    • 8.5.1. Brazil Insulin Delivery Devices Market
    • 8.5.2. Mexico Insulin Delivery Devices Market
  • 8.6. Rest of The World Insulin Delivery Devices Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Becton, Dickinson and Company
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Novo Nordisk A/S
    • 9.2.3. Medtronic PLC
    • 9.2.4. Sanofi
    • 9.2.5. ELI Lilly and Company
    • 9.2.6. Ypsomed Holding AG
    • 9.2.7. Animas Corporation (Johnson and Johnson)
    • 9.2.8. Tandem Diabetes Care, Inc.
    • 9.2.9. Insulet Corporation
    • 9.2.10. Biocon Limited

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption